Becton Dickinson and Co. (NYSE:BDX)’s share price reached a new 52-week high during trading on Monday . The stock traded as high as $177.85 and last traded at $176.79, with a volume of 393,913 shares. The stock had previously closed at $175.47.

Several equities analysts recently commented on BDX shares. Bank of America Corp. restated a “buy” rating on shares of Becton Dickinson and in a research report on Tuesday, July 12th. Cowen and Company restated an “outperform” rating and set a $185.00 target price on shares of Becton Dickinson and in a research report on Tuesday, August 16th. Jefferies Group restated a “buy” rating on shares of Becton Dickinson and in a research report on Friday, August 5th. Evercore ISI restated a “hold” rating and set a $165.00 target price (up from $154.00) on shares of Becton Dickinson and in a research report on Saturday, May 7th. Finally, Royal Bank Of Canada lifted their price target on Becton Dickinson and from $153.00 to $169.00 and gave the stock a “sector perform” rating in a research note on Monday, May 9th. Eight investment analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $169.46.

The stock has a market capitalization of $37.68 billion and a PE ratio of 33.77. The firm’s 50-day moving average price is $174.73 and its 200 day moving average price is $162.58.

Becton Dickinson and (NYSE:BDX) last issued its earnings results on Thursday, August 4th. The company reported $2.35 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.21 by $0.14. During the same period in the previous year, the firm earned $2.05 EPS. The firm earned $3.20 billion during the quarter, compared to analysts’ expectations of $3.21 billion. The firm’s revenue was up 2.5% on a year-over-year basis. Equities research analysts forecast that Becton Dickinson and Co. will post $8.57 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, September 30th. Stockholders of record on Friday, September 9th will be issued a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 1.50%. The ex-dividend date is Wednesday, September 7th.

In related news, EVP Nabil Shabshab sold 5,080 shares of the firm’s stock in a transaction dated Tuesday, June 7th. The shares were sold at an average price of $168.75, for a total value of $857,250.00. Following the completion of the sale, the executive vice president now owns 11,092 shares in the company, valued at $1,871,775. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP John E. Gallagher sold 1,931 shares of the firm’s stock in a transaction dated Monday, June 13th. The shares were sold at an average price of $169.87, for a total transaction of $328,018.97. Following the completion of the sale, the vice president now owns 6,758 shares of the company’s stock, valued at approximately $1,147,981.46. The disclosure for this sale can be found here.

Several hedge funds recently made changes to their positions in the stock. Schwab Charles Investment Management Inc. boosted its position in shares of Becton Dickinson and by 2.7% in the fourth quarter. Schwab Charles Investment Management Inc. now owns 585,304 shares of the company’s stock worth $90,190,000 after buying an additional 15,361 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in shares of Becton Dickinson and by 3.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 348,912 shares of the company’s stock worth $53,767,000 after buying an additional 11,489 shares during the last quarter. Finally, American International Group Inc. boosted its position in shares of Becton Dickinson and by 2.7% in the fourth quarter. American International Group Inc. now owns 81,525 shares of the company’s stock worth $12,563,000 after buying an additional 2,121 shares during the last quarter.

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.